Clinical Trial Update: A Prospective Cohort Study on Primary Cutaneous Amyloidosis [Phase 4]

View source ↗

Summary

A Phase 4 prospective cohort study of primary cutaneous amyloidosis is recruiting. The study is sponsored by Army Medical University in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Amyloidosis

Snippet

Sponsor: Army Medical University, China | Conditions: Primary Cutaneous Amyloidosis | Phase 4 | Status: RECRUITING